Pharmacogenomic-guided drug development: regulatory perspective.
- Published in:
- Pharmacogenomics Journal, 2002, v. 2, n. 1, p. 20, doi. 10.1038/sj.tpj.6500046
- By:
- Publication type:
- Article
Works matching IS 1470269X AND DT 2002 AND VI 2 AND IP 1
Results: 17
1
2
Feeling below PAR: proteinase-activated receptors and the perception of neuroinflammatory pain.
- Published in:
- Pharmacogenomics Journal, 2002, v. 2, n. 1, p. 10, doi. 10.1038/sj.tpj.6500071
- By:
- Publication type:
- Article
3
UGT1A1*28 polymorphism as a determinant of irinotecan disposition and toxicity.
- Published in:
- Pharmacogenomics Journal, 2002, v. 2, n. 1, p. 43, doi. 10.1038/sj.tpj.6500072
- By:
- Publication type:
- Article
4
Adiponectin enhances insulin action by decreasing ectopic fat deposition.
- Published in:
- Pharmacogenomics Journal, 2002, v. 2, n. 1, p. 4, doi. 10.1038/sj.tpj.6500068
- By:
- Publication type:
- Article
5
The HUGO Mutation Database Initiative.
- Published in:
- Pharmacogenomics Journal, 2002, v. 2, n. 1, p. 16
- By:
- Publication type:
- Article
6
Pharmacogenomics—Is there a role in antibiotic therapy?
- Published in:
- Pharmacogenomics Journal, 2002, v. 2, n. 1, p. 14, doi. 10.1038/sj.tpj.6500064
- By:
- Publication type:
- Article
7
Pharmacogenetics of the arylamine N-acetyltransferases.
- Published in:
- Pharmacogenomics Journal, 2002, v. 2, n. 1, p. 30, doi. 10.1038/sj.tpj.6500053
- By:
- Publication type:
- Article
8
A unique mouse model for succinic semialdehyde dehydrogenase deficiency with implications for gamma hydroxybutyrate intoxication.
- Published in:
- Pharmacogenomics Journal, 2002, v. 2, n. 1, p. 3, doi. 10.1038/sj.tpj.6500074
- By:
- Publication type:
- Article
9
Metastatic medulloblastoma—therapeutic success through molecular target identification?
- Published in:
- Pharmacogenomics Journal, 2002, v. 2, n. 1, p. 7
- By:
- Publication type:
- Article
10
Searching for type 2 diabetes genes: prospects in pharmacotherapy.
- Published in:
- Pharmacogenomics Journal, 2002, v. 2, n. 1, p. 25, doi. 10.1038/sj.tpj.6500078
- By:
- Publication type:
- Article
11
Tetanus antigen modulates the gene expression profile of aluminum phosphate adjuvant in spleen lymphocytes in vivo.
- Published in:
- Pharmacogenomics Journal, 2002, v. 2, n. 1, p. 57
- By:
- Publication type:
- Article
12
Both populations and individuals are evolutionary targets: pharmacogenomic and cultural indicators.
- Published in:
- Pharmacogenomics Journal, 2002, v. 2, n. 1, p. 12, doi. 10.1038/sj.tpj.6500083
- By:
- Publication type:
- Article
13
Human sulfotransferase SULT2A1 pharmacogenetics: genotype-to-phenotype studies.
- Published in:
- Pharmacogenomics Journal, 2002, v. 2, n. 1, p. 48, doi. 10.1038/sj.tpj.6500089
- By:
- Publication type:
- Article
14
Sexual dimorphism of the catechol-O-methyltransferase gene in narcolepsy is associated with response to modafinil.
- Published in:
- Pharmacogenomics Journal, 2002, v. 2, n. 1, p. 65, doi. 10.1038/sj.tpj.6500088
- By:
- Publication type:
- Article
15
In This Issue.
- Published in:
- Pharmacogenomics Journal, 2002, v. 2, n. 1, p. 2, doi. 10.1038/sj.tpj.6500092
- Publication type:
- Article
16
State of the art and electronic submission of manuscripts.
- Published in:
- Pharmacogenomics Journal, 2002, v. 2, n. 1, p. 1, doi. 10.1038/sj.tpj.6500093
- By:
- Publication type:
- Article
17
Vesicular protein transport.
- Published in:
- Pharmacogenomics Journal, 2002, v. 2, n. 1, p. 69, doi. 10.1038/sj.tpj.6500097
- By:
- Publication type:
- Article